Le Lézard
Classified in: Health
Subjects: NPT, LEG

End SUD Endorses The Mainstreaming Addiction Treatment Act


AUSTIN, Texas, Feb. 25, 2021 /PRNewswire/ -- Today, bipartisan members of Congress re-introduced the Mainstreaming Addiction Treatment Act ? legislation that will help build universal access to lifesaving treatment for opioid use disorder. The bill, which won the support of over 100 members of Congress last session and was included in President Biden's plan on the opioid crisis, can save tens of thousands of Americans every year from overdose deaths.

The Mainstreaming Addiction Treatment Act will help ensure every person with opioid use disorder has access to one of the gold standards of care: buprenorphine. Buprenorphine cuts the risk of overdose death in half and helps secure long-term recovery. Buprenorphine is a safe medication that has been FDA-approved for nearly twenty years and is available in generic form.

But as few as 1 in 5 Americans with opioid use disorder have received buprenorphine due to onerous federal burdens on healthcare providers who treat patients with opioid use disorder. Women, persons of color, veterans, and rural Americans all lack equal access to buprenorphine due to the structural health disparities caused by current federal law.

"The Mainstreaming Addiction Treatment Act is a common-sense solution to the overdose crisis that will increase participation in treatment, help eliminate stigma, and reduce healthcare and criminal justice costs," said Erin Schanning, President of End SUD and a big sister who lost her little brother to an overdose. "The bill is rooted in the simple truth that substance use disorder is not a moral failing but rather a medical condition that we can prevent and treat with healthcare."

End SUD thanks Senators Maggie Hassan and Lisa Murkowski and Representatives Paul Tonko, Michael Turner, Antonio Delgado, and Anthony Gonzalez for their leadership to build access to safe, high-quality treatment that can help the 2.3 million Americans with opioid use disorder recover.

To learn more about the Mainstreaming Addiction Treatment Act, visit www.endsud.org/mat-act

About End SUD

End SUD is a national, nonpartisan campaign that advances policies to prevent and treat substance use disorder. The nonprofit advocacy organization leads coalitions of healthcare and behavioral health providers, people and families with substance use disorder, harm reduction advocates, law enforcement officers, social justice leaders, and local and state officials that serve millions of Americans. Learn more at www.endsud.org

 

SOURCE End SUD


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: